Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Atrial Fibrillation Management and Outcomes, Lipoproteins and Cardiovascular Health, Cardiac Imaging and Diagnostics, and Cardiovascular Disease and Adiposity.
Abstract 4144036: Association of PM <sub>2.5</sub> Air Pollution with Inflammatory Biomarkers in Patients with Heart Failure
Abstract 4139462: Admission and Discharge B-Natriuretic Peptide Profiles Are Predictive of 1-Year Mortality Above Intermountain Risk Score in Heart Failure Phenotypes
Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events
Impact of Statin Therapy in Heart Failure Patients
Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare Experience
Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial
Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance
Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population
High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES study
Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease
Economics and outcomes of sotalol in‐patient dosing approaches in patients with atrial fibrillation
Association of periodic fasting lifestyles with survival and incident major adverse cardiovascular events in patients undergoing cardiac catheterization
Spectrum of radionuclide perfusion study abnormalities in takotsubo cardiomyopathy
Predictors of Statin Intolerance in Patients With a New Diagnosis of Atherosclerotic Cardiovascular Disease Within a Large Integrated Health Care Institution: The IMPRES Study
Frequency and Clinical Impact of Hyperkalaemia Within a Large, Modern, Real-World Heart Failure Population
Stroke and dementia risk in patients with and without atrial fibrillation and carotid arterial disease
Free thyroxine within the normal reference range predicts risk of atrial fibrillation
The association of depression at any time to the risk of death following coronary artery disease diagnosis
Five‐year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke
Long‐term aspirin does not lower risk of stroke and increases bleeding risk in low‐risk atrial fibrillation ablation patients
Both initial red cell distribution width (<scp>RDW</scp>) and change in <scp>RDW</scp> during heart failure hospitalization are associated with length of hospital stay and 30‐day outcomes
A Comparison of Remote Magnetic Irrigated Tip Ablation versus Manual Catheter Irrigated Tip Catheter Ablation With and Without Force Sensing Feedback
β-blocker dosage and outcomes after acute coronary syndrome
Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System
The Impact of Age on 5‐Year Outcomes After Atrial Fibrillation Catheter Ablation
Long-Term Natural History of Adult Wolff–Parkinson–White Syndrome Patients Treated With and Without Catheter Ablation
Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High-Risk Patients With Diabetes
Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score
A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)